...
首页> 外文期刊>Journal of neural transmission >Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder
【24h】

Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder

机译:自闭症谱系障碍儿童和青少年血液中外周BDNF mRNA表达和BDNF蛋白浓度的变化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Findings from molecular genetic studies and analyses of postmortem and peripheral tissue led to the hypothesis that neurotrophins-as crucial moderators of neuroplasticity-impact on the pathophysiology of autism spectrum disorder (ASD). The study projects aimed to complement former results on the role of brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family with fundamental impact on brain development and function. The purpose of this work was to investigate peripheral BDNF mRNA expression and BDNF protein concentrations in ASD as potential surrogates for the effects observed in the central nervous system. In a BDNF protein quantification study, serum concentrations were analyzed using Enzyme-Linked Immunosorbent Assays in 24 male patients with ASD, all with an IQ 70 (age 13.9 ± 3.0 years) and 20 age- and gender-matched healthy control subjects (age 14.4 ± 2.1 years; p = 0.522). In a further independent project, a BDNF mRNA expression analysis, mRNA levels from total blood were assessed by quantitative real-time polymerase chain reaction in a sample of 16 male ASD patients (age 10.8 ± 2.2), 15 age- and gender-matched healthy controls (age 12.1 ± 2.2) and 15 patients with attention deficit hyperactivity disorder as a clinical control group (age 11.8 ± 2.2; p = 0.207). In the protein quantification project, significantly decreased BDNF serum concentrations were found in ASD cases compared to healthy control children (t = -2.123, df = 42, p 0.05). Analysis of covariance (ANCOVA) revealed this result in accordance with significant reductions in BDNF mRNA expression in ASD, observed in the mRNA expression study (F = 3.65; df = 2.43; p 0.05); neither age nor IQ confounded the result, as indicated by ANCOVA (F = 3.961; df = 2.41; p 0.05, η 2 = 0.162). Our study projects supported the notion that neurotrophins are involved in the pathophysiology of ASD. Further studies may eventually contribute to the identification of distinct peripheral mRNA expression and protein concentration patterns possibly supporting diagnostic and therapeutic processes.
机译:分子遗传学研究的结果以及对尸体和外周组织的分析结果得出这样的假设:神经营养蛋白作为神经可塑性的重要调节剂,会影响自闭症谱系障碍(ASD)的病理生理。该研究项目旨在补充先前关于脑源性神经营养因子(BDNF)的作用的结果,BDNF是神经营养蛋白家族的成员,对脑的发育和功能具有根本性影响。这项工作的目的是调查在ASD中外周BDNF mRNA表达和BDNF蛋白浓度,作为在中枢神经系统中观察到的作用的潜在替代物。在BDNF蛋白质定量研究中,使用酶联免疫吸附测定法分析了24名男性IQ≥70(年龄为13.9±3.0岁)的男性ASD患者以及20名年龄和性别相匹配的健康对照受试者(年龄)的血清浓度14.4±2.1年; p = 0.522)。在另一个独立的项目BDNF mRNA表达分析中,通过定量实时聚合酶链反应评估了16名男性ASD患者(年龄10.8±2.2),15位年龄和性别相匹配的健康人群中全血mRNA水平对照组(12.1±2.2岁)和15名注意力不足过动症患者作为临床对照组(11.8±2.2岁; p = 0.207)。在蛋白质定量项目中,与健康对照儿童相比,ASD患者的BDNF血清浓度明显降低(t = -2.123,df = 42,p <0.05)。协方差分析(ANCOVA)表明,该结果与在mRNA表达研究中观察到的ASD中BDNF mRNA表达的显着降低(F = 3.65; df = 2.43; p <0.05)有关。 ANCOVA指出,年龄和智商都不会混淆结果(F = 3.961; df = 2.41; p <0.05,η2 = 0.162)。我们的研究项目支持了神经营养蛋白参与ASD病理生理的观点。进一步的研究可能最终有助于识别独特的外周mRNA表达和蛋白质浓度模式,从而可能支持诊断和治疗过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号